![Frank W. Oertel](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Frank W. Oertel
Directeur/Membre du Conseil chez BioAgency AG
Profil
Frank W.
Oertel is the founder of Indivumed GmbH, which was founded in 2002.
Currently, he holds the position of Member-Supervisory Board at BioAgency AG.
Postes actifs de Frank W. Oertel
Sociétés | Poste | Début |
---|---|---|
BioAgency AG
![]() BioAgency AG Financial ConglomeratesFinance BioAgency AG provides financing services. The company is headquartered in Hamburg, Germany. | Directeur/Membre du Conseil | - |
Anciens postes connus de Frank W. Oertel
Sociétés | Poste | Fin |
---|---|---|
Indivumed GmbH
![]() Indivumed GmbH Data Processing ServicesTechnology Services Indivumed GmbH engages in the research and development of medical treatment for cancer patients. The firm develops an integrated analytical platform, which links sample sets from cancer patients such as tissue types, serum, plasma, and urine with a web-accessible database. It offers treatment for the people suffering from GI-tract such as colorectal, gastric, pancreatic, breast, and lung cancer. The company was founded by Hartmut Juhl, Carsten Zornig and Peter Layer in April 2002 and is headquartered in Hamburg, Germany. | Fondateur | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
BioAgency AG
![]() BioAgency AG Financial ConglomeratesFinance BioAgency AG provides financing services. The company is headquartered in Hamburg, Germany. | Finance |
Indivumed GmbH
![]() Indivumed GmbH Data Processing ServicesTechnology Services Indivumed GmbH engages in the research and development of medical treatment for cancer patients. The firm develops an integrated analytical platform, which links sample sets from cancer patients such as tissue types, serum, plasma, and urine with a web-accessible database. It offers treatment for the people suffering from GI-tract such as colorectal, gastric, pancreatic, breast, and lung cancer. The company was founded by Hartmut Juhl, Carsten Zornig and Peter Layer in April 2002 and is headquartered in Hamburg, Germany. | Technology Services |